ITEM VIEW

Interferon - the clinical experience

dc.contributor.authorVan Helden P.D.
dc.date.accessioned2011-03-18T14:57:41Z
dc.date.available2011-03-18T14:57:41Z
dc.date.issued1983
dc.identifier.issn2078-5135 (online)
dc.identifier.issn0256-9574 (print)
dc.identifier.urihttp://hdl.handle.net/10019.1/7588
dc.descriptionReview
dc.descriptionThe original publication is available at http://www.samj.org.za
dc.description.abstractRecent trials with interferon, in particular those using pure, recombinant interferon, have provided us with improved data (compared with those obtained in early studies) and show that interferon does hold some promise as a therapeutic agent. When used in the treatment of viral disease, interferon has shown itself to be quite effective in reducing viral titres. While not as effective against cancer, interferon has limited tumour growth, reduced the appearance of metastases and led to a general improvement in patient condition in many cases. This article discusses some of the recent results obtained with interferon in the treatment of viral disease and cancer.
dc.language.isoen
dc.publisherHealth & Medical Publishing Group
dc.titleInterferon - the clinical experienceen_ZA
dc.typeReview
dc.description.versionPublisher’s version
dc.rights.holderSouth African Medical Journal


Files in this item

Thumbnail

This item appears in the following Collection(s)

  • BB - Editors654

    Items (SAMJ) with full text to be edited by metadata editors and moved to final destination collection.

ITEM VIEW